Design Therapeutics Inc (DSGN)
Healthcare
Biotechnology
—
12.20 $
-3.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Design Therapeutics Inc (DSGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.6% of the shares are freely tradable; institutional investors hold 62.1%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
62.1%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
31.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
52.6%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
9.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
63Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 10.45 | 6,526,476 | +0.0 | 12/31/2025 |
| RA Capital Management, LLC | 4.76 | 2,972,973 | +103.4 | 03/31/2026 |
| Point72 Asset Management, L.P. | 4.36 | 2,722,754 | -49.3 | 03/31/2026 |
| Baker Bros Advisors LP | 4.14 | 2,585,978 | +15.8 | 03/31/2026 |
| BlackRock Inc | 3.42 | 2,133,764 | +0.8 | 03/31/2026 |
| Logos Global Management LP | 3.12 | 1,950,000 | -22.0 | 03/31/2026 |
| Driehaus Capital Management LLC | 2.79 | 1,744,987 | +47.9 | 03/31/2026 |
| Vanguard Group Inc | 2.61 | 1,630,910 | +13.0 | 12/31/2025 |
| Vivo Capital, LLC | 2.58 | 1,612,903 | +0.0 | 03/31/2026 |
| Almitas Capital LLC | 2.45 | 1,530,435 | -50.0 | 12/31/2025 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.